Search details
1.
Improved survival in myeloma patients-a nationwide registry study of 4,647 patients ≥75 years treated in Denmark and Sweden.
Haematologica
; 108(6): 1640-1651, 2023 06 01.
Article
in English
| MEDLINE | ID: mdl-36300775
2.
Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries.
Eur J Haematol
; 108(2): 99-108, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34514635
3.
Ixazomib-Thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autologous stem cell transplantation; results from the randomized phase II HOVON-126/NMSG 21.13 trial.
Haematologica
; 105(12): 2879-2882, 2020 12 01.
Article
in English
| MEDLINE | ID: mdl-33256392
4.
Regional differences in treatment and outcome for myeloma patients in Sweden: A population based Swedish myeloma register study.
Cancer Rep (Hoboken)
; 5(11): e1614, 2022 11.
Article
in English
| MEDLINE | ID: mdl-35243814
5.
Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13.
Hemasphere
; 7(9): e940, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37663673
Results
1 -
5
de 5
1
Next >
>>